Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City
Tóm tắt
Từ khóa
Tài liệu tham khảo
Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL: Unconventional medicine in the United States prevalence, costs, and patterns of use. N Engl J Med. 1993, 328: 246-252. 10.1056/NEJM199301283280406.
Complementary and Alternative Medicine Used in the United States. Accessed 29 June 2004, [ http://nccam.nih.gov/news/graphics.htm ]
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Rompay MV, Kessler RC: Trends in alternative medicine use in the United States, 1990 – 1997 Results of a follow-up national survey. JAMA. 1998, 280: 1569-157. 10.1001/jama.280.18.1569.
Kesser RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ, Eisenberg DM: Long-term trends in use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001, 135: 262-268.
Chandola A, Young Y, McAlister J, Axford JS: Use of complementary therapies by patients attending musculoskeletal clinics. J R Soc Med. 1999, 92: 13-16.
Anderson DL, McWhorter LS, Crouch BI, Andersen SJ: Prevalence and patterns of alternative medication use in the university hospital outpatient clinic serving rheumatology and geriatric patients. Pharmacotherapy. 2000, 20: 958-966. 10.1592/phco.20.11.958.35257.
Burstein HJ, Gelber S, Guadagnoli E, Weeks JC: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999, 340: 1733-1739. 10.1056/NEJM199906033402206.
Cassileth BR, Luck EJ, Strouse TB, Bodenheimer BJ: Contemporary unorthodox treatments in cancer medicine. Ann Intern Med. 1984, 101: 105-112.
Fernandez CV, Stutzer CA, MacWilliam L, Fryer C: Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol. 1998, 16: 1279-1286.
Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS: Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med. 1998, 158: 2257-2264. 10.1001/archinte.158.20.2257.
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996, 347: 781-786. 10.1016/S0140-6736(96)90866-1.
Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000, 342: 154-160. 10.1056/NEJM200001203420302.
Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP: Randomized trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction. Lancet. 1997, 349: 1715-1720. 10.1016/S0140-6736(97)01234-8.
Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF, Vita JA: Treatment of hypertension with ascorbic acid. Lancet. 1999, 354: 2048-2049. 10.1016/S0140-6736(99)04410-4.
GISSI-Prevenzione Investigators: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999, 354: 447-455. 10.1016/S0140-6736(99)07072-5.
von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H: The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double blind, placebo-controlled trial. Ann Intern Med. 1999, 130: 554-562.
Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M: Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival – 4. Cardiovasc Drugs Ther. 1997, 11: 485-491. 10.1023/A:1007757724505.
Soja AM, Mortensen SA: Treatment of congestive heart failure with coenzyme Q 10 illuminated by meta-analyses of clinical trails. Molec Aspects Med. 1997, 18: 159-168. 10.1016/S0098-2997(97)00042-3.
Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, Gottlieb SS: The effect of coenzyme Q10 in patients with congestive heart failure. Ann Intern Med. 2000, 132: 636-40.
Ackman ML, Cambell JB, Buzak KA, Tsuyuki RT, Montague TJ, Teo KK: Use of nonprescription medications by patients with congestive heart failure. Ann Pharmacother. 1999, 33: 674-679. 10.1345/aph.18283.
Liu EH, Turner LM, Lin SX, Klaus L, Choi LY, Whitworth J, Ting W, Oz MC: Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2000, 120: 335-41. 10.1067/mtc.2000.107339.
Ai AL, Bolling SF: The use of complementary and alternative therapies among middle-aged and older cardiac patients. American Journal of Medical Quality. 2002, 17: 21-27.
Wood MJ, Stewart RL, Merry H, Johnstone DE, Cox JL: Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J. 2003, 145: 806-12. 10.1016/S0002-8703(03)00084-X.
Pharand C, Ackman ML, Jackevicius CA, Paradiso-Hardy F, Pearson GJ: Use of OTC and herbal products in patients with cardiovascular disease. Ann Pharmacother. 2003, 37: 899-904. 10.1345/aph.1C163.
Reuning RH, Geraets DR, Rocci ML, Vlasses PH: Digoxin. Applied Pharmacokinetics Principles of Therapeutic Drug Monitoring. Edited by: Evans WE, Schentag JJ, Jusko WJ, Relling MV. 1992, Vancouver, WA: Applied Therapeutics, Inc, 20-29. 3
Porter RS, Sawyer WT: Warfarin. Applied Pharmacokinetics Principles of Therapeutic Drug Monitoring. Edited by: Evans WE, Schentag JJ, Jusko WJ, Relling MV. 1992, Vancouver, WA: Applied Therapeutics, Inc, 31-8-31-13. 3
MICROMEDEX® Healthcare Series Integrated Index: Thomson MICROMEDEX. Vol. 120 expires 6/2004
Steiner M: Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease. Nutr Rev. 1999, 57: 306-309.
Liede KE, Haukka JK, Saxen LM, Heinonen OP: Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. Ann Med. 1998, 30: 542-546.
Vitamin E Monograph: Natural Medicines Comprehensive Database. Accessed April 22, 2001, [ http://www.naturaldatabase.com ]
Heck AM, DeWitt BA, Lukes AL: Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000, 57: 1221-1227.
Corrigan JJ: The effect of vitamin E on warfarin-induced vitamin K deficiency. Ann N Y Acad Sci. 1982, 393: 361-368.
Corrigan JJ, Ulfers LL: Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. Am J Clin Nutr. 1981, 34: 1701-1705.
Vaes LP, Chyka PA: Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother. 2000, 34: 1478-1482.
Miller LG: Herbal medicines: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med. 1998, 158: 2200-2211. 10.1001/archinte.158.20.2200.
Garlic Monograph: Natural Medicines Comprehensive Database. Accessed April 22, 2001, [ http://www.naturaldatabase.com ]
Sakamoto N, Nishiike T, Iguchi H, Sakamoto K: Effects of eicosapentaenoic acid intake on plasma fibrinolytic and coagulation activity by using physical load in the young. Nutrition. 2000, 16: 11-14. 10.1016/S0899-9007(99)00181-1.
Guivernau M, Meza N, Barja P, Roman O: Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid and plasma lipids, platelet aggregation, thromboxane formation and prostacyclin production. Prostaglandins Leurotrienes and Essential Fatty Acids. 1994, 51: 311-316. 10.1016/0952-3278(94)90002-7.
Spigset O: Reduced effect of warfarin caused by ubidecarenone. Lancet. 1994, 334: 1372-1373. 10.1016/S0140-6736(94)90736-6.
Landbo C, Almdal TP: Interaction between warfarin and coenzyme Q10. (Abstract in English). Ugeskr Laeger. 1998, 160: 3226-3227.